These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32382893)

  • 41. Salvage esophagectomy for initially unresectable locally advanced T4 esophageal squamous cell carcinoma.
    Okamura A; Hayami M; Kozuki R; Takahashi K; Toihata T; Imamura Y; Mine S; Watanabe M
    Esophagus; 2020 Jan; 17(1):59-66. PubMed ID: 31595397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Salvage endoscopic submucosal dissection for the esophagus-localized recurrence of esophageal squamous cell cancer after definitive chemoradiotherapy.
    Koizumi S; Jin M; Matsuhashi T; Tawaraya S; Watanabe N; Sawaguchi M; Kanazawa N; Yamada Y; Onochi K; Kimura Y; Ohba R; Kataoka J; Hatakeyma N; Mashima H; Ohnishi H
    Gastrointest Endosc; 2014 Feb; 79(2):348-53. PubMed ID: 24125510
    [No Abstract]   [Full Text] [Related]  

  • 43. Prognostic Impact of Postoperative Complications following Salvage Esophagectomy for Esophageal Cancer after Definitive Chemoradiotherapy.
    Sugimura K; Miyata H; Shinno N; Ushigome H; Asukai K; Hara H; Hasegawa S; Yamada D; Yamamoto K; Haraguchi N; Nishimura J; Motoori M; Wada H; Takahashi H; Yasui M; Omori T; Ohue M; Yano M
    Oncology; 2020; 98(5):280-288. PubMed ID: 32155643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Salvage endoscopic submucosal dissection in patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma.
    Takeuchi M; Kobayashi M; Hashimoto S; Mizuno K; Kawaguchi G; Sasamoto R; Aoyama H; Aoyagi Y
    Scand J Gastroenterol; 2013 Sep; 48(9):1095-101. PubMed ID: 23906093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The emerging role of salvage esophagectomy.
    Lee D; Chiu L; Kim JY
    Minerva Chir; 2013 Aug; 68(4):353-65. PubMed ID: 24019043
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
    Yano T; Muto M; Hattori S; Minashi K; Onozawa M; Nihei K; Ishikura S; Ohtsu A; Yoshida S
    Endoscopy; 2008 Sep; 40(9):717-21. PubMed ID: 18773340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clonal Expansion of Tumor-Infiltrating T Cells and Analysis of the Tumor Microenvironment within Esophageal Squamous Cell Carcinoma Relapsed after Definitive Chemoradiation Therapy.
    Mori T; Kumagai K; Nasu K; Yoshizawa T; Kuwano K; Hamada Y; Kanazawa H; Suzuki R
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? A critical review.
    Tsou YK; Lee CH; Le PH; Chen BH
    Crit Rev Oncol Hematol; 2020 Mar; 147():102883. PubMed ID: 32014674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Knack and Pitfalls of Salvage Esophagectomy].
    Yamashita K; Yamasaki M
    Kyobu Geka; 2020 Sep; 73(10):883-886. PubMed ID: 33130784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does cervical lymph node recurrence after oesophagectomy or definitive chemoradiotherapy for thoracic oesophageal squamous cell carcinoma benefit from salvage treatment?
    Yuan X; Lv J; Dong H; Wang J
    Interact Cardiovasc Thorac Surg; 2017 May; 24(5):792-795. PubMed ID: 28453803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is the outcome of a salvage surgery for T4 thoracic esophageal squamous cell carcinoma really poor?
    Akutsu Y; Kono T; Uesato M; Hoshino I; Murakami K; Aoyagi T; Ota T; Toyozumi T; Suito H; Kobayashi H; Harada R; Uno T; Matsubara H
    World J Surg; 2014 Nov; 38(11):2891-7. PubMed ID: 24952078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Salvage Esophagectomy After Definitive Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Who Really Benefits from this High-Risk Surgery?
    Watanabe M; Mine S; Nishida K; Yamada K; Shigaki H; Matsumoto A; Sano T
    Ann Surg Oncol; 2015 Dec; 22(13):4438-44. PubMed ID: 25862582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Review of early endoscopic findings in patients with local recurrence after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
    Yamamoto Y; Kadota T; Yoda Y; Hori K; Hatogai K; Kojima T; Fujii S; Akimoto T; Yano T
    Esophagus; 2020 Oct; 17(4):433-439. PubMed ID: 32232702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
    Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy.
    Molena D; Sun HH; Badr AS; Mungo B; Sarkaria IS; Adusumilli PS; Bains MS; Rusch VW; Ilson DH; Rizk NP
    Dis Esophagus; 2014; 27(4):355-9. PubMed ID: 24033404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Salvage photodynamic therapy for local failure after chemoradiotherapy for esophageal squamous cell carcinoma.
    Hatogai K; Yano T; Kojima T; Onozawa M; Daiko H; Nomura S; Yoda Y; Doi T; Kaneko K; Ohtsu A
    Gastrointest Endosc; 2016 Jun; 83(6):1130-1139.e3. PubMed ID: 26608125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retrospective analysis of neoadjuvant chemotherapy followed by surgery versus definitive chemoradiotherapy with proton beam for locally advanced esophageal squamous cell carcinoma.
    Ogawa K; Ishikawa H; Hisakura K; Hiroshima Y; Moriwaki T; Yamada T; Yamamoto Y; Akashi Y; Owada Y; Ohara Y; Enomoto T; Furuya K; Doi M; Shimomura O; Takahashi K; Hashimoto S; Sakurai H; Oda T
    Int J Clin Oncol; 2021 Oct; 26(10):1856-1863. PubMed ID: 34241725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison Between Esophagectomy and Definitive Chemoradiotherapy in Patients With Esophageal Cancer.
    Wang BY; Hung WH; Wu SC; Chen HC; Huang CL; Lin CH; Chen HS
    Ann Thorac Surg; 2019 Apr; 107(4):1060-1067. PubMed ID: 30571951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients.
    Chen CY; Li CC; Chien CR
    World J Surg Oncol; 2018 Jul; 16(1):141. PubMed ID: 30007409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.